1. Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
   Dorothee Heck et al, 2015, Hormones and Cancer CrossRef
2. A Concise Review on the Role of Natural and Synthetically Derived Peptides in Colorectal Cancer
   Alakesh Das et al, 2022, Current Topics in Medicinal Chemistry CrossRef
3. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer
   Takanori Goi et al, 2015, Oncotarget CrossRef
4. The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer
   Takanori Goi et al, 2015, Oncotarget CrossRef
5. The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1(No correlation coefficient between VEGF and PROK1)
   Takanori Goi et al, 2015, Oncotarget CrossRef
6. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis
   Mohammed Benlahfid et al, 2018, Cancer Biomarkers CrossRef
7. The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis
   Lucia Negri et al, 2018, Physiological Reviews CrossRef
8. Prokineticin 1 Protein Expression is a Useful New Prognostic Factor for Human Sporadic Colorectal Cancer
   Toshiyuki Nakazawa et al, 2015, Annals of Surgical Oncology CrossRef
9. Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study
   Noriyuki Tagai et al, 2021, World Journal of Surgical Oncology CrossRef
10. Anti-Prokineticin1 (PROK1) Monoclonal Antibody Suppresses Angiogenesis and Tumor Growth in Colorectal Cancer
    Takanori Goi et al, 2014, Annals of Surgical Oncology CrossRef
11. Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis
    Ana Silvia Corlan et al, 2017, International Journal of Endocrinology CrossRef